which glp-1 drugs are approved for obesity Comparing Ozempic, Wegovy and Other Dozens of new obesity drugs

11 were in the final stages of clinical trials as of June 2024 [112] Among others, Hangzhou Jiuyuan Gene Engineering, The United Laboratories, CSPC Pharmaceutical Group, Huadong Medicine (which also holds a majority stake in Jiuyuan Gene [115] ) and Sihuan Pharmaceutical were all preparing generic offerings

But that does not mean they are the right fit for everyone

Ongoing clinical research will determine whether the drug treatment of obesity can achieve the same curative effect as bariatric surgery

This highlights the need for further research to establish the safety and efficacy of semaglutide in patients with a history of psychiatric conditions

Due to its caffeine content, it is recommended not to take it in the evening or combine it with other caffeine sources (coffee, energy drinks)